Gentian Diagnostics Asa announced that Frank Frantzen has resigned from the Board of Directors effective immediately due to taking a role as CTO of Cardinor AS.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.8 NOK | +4.39% | +2.88% | +3.13% |
Apr. 30 | Gentian Diagnostics ASA Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 30 | Transcript : Gentian Diagnostics ASA, Q1 2024 Earnings Call, Apr 30, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.13% | 60.11M | |
-3.43% | 12.1B | |
-3.17% | 8.24B | |
+31.98% | 5.58B | |
-10.03% | 4.15B | |
-59.94% | 2.68B | |
+11.23% | 2.63B | |
-5.14% | 2.24B | |
+18.91% | 2.03B | |
-7.56% | 1.79B |
- Stock Market
- Equities
- GENT Stock
- News Gentian Diagnostics
- Gentian Diagnostics Asa Announces Resignation of Frank Frantzen from the Board of Directors